Patent details

Basic Information

Publication number:

EP2168571

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP091735662

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Particles for use in a Pharmaceutical Composition

French Title of Invention:

Compositions pharmaceutiques pour inhalation

German Title of Invention:

Inhalierbare Arzneizusammensetzung

SPC Number:

Dates

Filing date:

30/11/2001

Grant date:

22/08/2018

EP Publication Date:

31/03/2010

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

22/08/2018

EP B1 Publication Date:

22/08/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

30/11/2018

Expiration date:

30/11/2021

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

15/08/2018

 

 

Name:

Vectura Limited

Address:

1 Prospect West, Chippenham, Wiltshire SN14 6FH, United Kingdom (GB)

Inventor

1

Name:

Morton, David AlexanderVodden

Address:

Australia (AU)

2

Name:

Staniforth, John Nicolas

Address:

United Kingdom (GB)

Priority

1

Priority Number:

0029261

Priority Date:

30/11/2000

Priority Country:

United Kingdom (GB)

2

Priority Number:

0030946

Priority Date:

19/12/2000

Priority Country:

United Kingdom (GB)

3

Priority Number:

0124009

Priority Date:

05/10/2001

Priority Country:

United Kingdom (GB)

Classification

IPC classification:

A61K 9/00; A61K 47/28;

Publication

European Patent Bulletin

Issue number:

201834

Publication date:

22/08/2018

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
30/03/2019	Outgoing Correspondence	1